MedPath

effect of Pippali and Guduchi on participants suffering from Hyperlipidemia

Phase 2/3
Not yet recruiting
Conditions
Hyperlipidemia, unspecified. Ayurveda Condition: MEDOROGAH,
Registration Number
CTRI/2025/04/084847
Lead Sponsor
Govt Auto Dhanwantri Ayurved Medical College
Brief Summary

This is randomized interventional " A Comparative clinical study of Pippali Churna (Piper longum Linn.) and Guduchi churna (Tinospora cordifolia Willd.) on Medoroga W.S.R. to Hyperlipidemia". Patients will be selected randomly for the study and will be divided into 2 groups. Each group will contain 30 patients. For the present study patients of either sex having the age group of 20 to 65 years who will present with complains of sign and symptoms of Medoroga w.s.r. to Hyperlipidemia will be selected irrespective of their religion and occupation etc. from the OPD of Government Dhanwantri Ayurveda medical College & Hospital Ujjain M.P.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Diagnosed cases of hyperlipidemia on the basis of investigation and patients with clinical signs and symptoms of Medoroga as mentioned in Ayurveda and modern literature.

Exclusion Criteria

Patients suffering from type 1 Diabetes mellitus Tuberculosis Renal cirrhosis or carcinoma Pregnant women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in sign and symptoms of diseaseChange in sign and symptoms of disease at 7th week
Secondary Outcome Measures
NameTimeMethod
assessment of changes in clinical parameter after 15 days1st follow up at 15th day

Trial Locations

Locations (1)

Govt Auto Dhanwantri Ayurved Medical College

🇮🇳

Ujjain, MADHYA PRADESH, India

Govt Auto Dhanwantri Ayurved Medical College
🇮🇳Ujjain, MADHYA PRADESH, India
Dr Preeti Solanki
Principal investigator
9669557962
preetifly.solanki@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.